Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
54
days
Anti-angiogenic therapy as potential treatment for adenomyosis
AuthorsMarissa J. Harmsen; Lynda J. M. Juffermans; Muara O. Kroon; Arjan W. Griffioen; Judith A. F. Huirne
Affiliations1. Department of Obstetrics and Gynaecology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; 2. Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands; 3. Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands; 4. Cancer Center Amsterdam, Amsterdam, The Netherlands
160
days
Ref-1 is overexpressed in neovascular eye disease and targetable with a novel inhibitor
AuthorsAnbukkarasi Muniyandi; Gabriella D. Hartman; Kamakshi Sishtla; Ratan Rai; Cátia Gomes; Kristina Day; Yang Song; Andi R. Masters; Sara K. Quinney; Xiaoping Qi; Hailey Woods; Michael E. Boulton; Jason S. Meyer; Jonah Z. Vilseck; Millie M. Georgiadis; Mark R. Kelley; Timothy W. Corson
Affiliations1. Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, USA; 2. Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, USA; 3. Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, USA; 4. Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, USA; 5. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada; 6. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, USA; 7. Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, USA; 8. Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, USA; 9. Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, USA; 10. Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, USA; 11. Department of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, USA; 12. Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, USA; 13. Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, USA; 14. Department of Ophthalmology and Vision Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
81
days
A novel quantitative angiogenesis assay based on visualized vascular organoid
AuthorsYun Zhao; Mengze Sun; Zihang Pan; Weijing Kong; Zixuan Hong; Wei Zhang; Bingbing Sun; Jingjing Zhang; Xi Wang; Kai Wang
Affiliations1. Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Advanced Center of Cellular Homeostasis and Aging-Related Diseases, Clinical Stem Cell Research Center, Peking University Third Hospital, Peking University, Beijing, China; 2. TianXinFu (Beijing) Medical Appliance Co., Ltd., Beijing, China; 3. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China; 4. State Key Laboratory of Female Fertility Promotion, Department of Obstetrics and Gynecology, Peking University Third Hospital, Institute of Advanced Clinical Medicine, Peking University, Beijing, China
88
days
Effect of oral nintedanib vs placebo on epistaxis in hereditary hemorrhagic telangiectasia: the EPICURE multicenter randomized double-blind trial
AuthorsRuben Hermann; Vincent Grobost; Xavier Le-Guillou; Christian Lavigne; Antoine Parrot; Sophie Rivière; Julie Séguier; Anne-Emmanuelle Fargeton; Aurélie de-Montigny; Margaux Huot; Evelyne Decullier; Adeline Roux; Caroline Gervaise; César Cartier; Xavier Dufour; Margaux Grall; Frank Jegoux; Laurent Laccourreye; Justin Michel; Nicolas Saroul; Isabelle Wagner; Mallorie Kerjouan; Sophie Dupuis-Girod
Affiliations1. Service d’ORL, chirurgie cervico-faciale et d’audiophonologie, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; 2. Service de Médecine Interne, CHU Estaing, Clermont-Ferrand University Hospital, Clermont-Ferrand, France; 3. Medical Genetics Department, University Hospital of Poitiers, Poitiers, France; 4. Department of Internal Medicine and Clinical Immunology, Angers University Hospital, Angers, France; 5. Assistance Publique-Hôpitaux de Paris, Service de Pneumologie et Centre de Compétence de la Maladie de Rendu Osler, Hôpital Tenon, Paris, France; 6. Service de Médecine Interne A, Centre Hospitalier Universitaire, Montpellier, France; 7. CHU de Montpellier, Hôpital St Eloi, Service de médecine Interne A and Centre d’Investigation Clinique, Inserm, CIC 1411, Montpellier Cedex, France; 8. Aix-Marseille Univ, APHM, Médecine Interne, Hôpital de la Timone, Marseille, France; 9. Service de Génétique et centre de reference de la maladie de Rendu-Osler, Hôpital Femme-Mère-Enfants, Hospices Civils de Lyon, Bron, France; 10. Service de Biostatistique et Bioinformatique des HCL, Lyon, France; 11. Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France; 12. Service de pharmaceutique, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France; 13. Service d’ORL Centre Hospitalier Universitaire, Montpellier, France; 14. Service de Chirurgie ORL, Centre Hospitalier Universitaire de Poitiers, Poitiers, France; 15. Service de Chirurgie ORL, Centre Hospitalier Universitaire Pontchaillou, Rennes, France; 16. Service d’ORL, CHU d’Angers, Angers cedex 9, France; 17. Department of Otorhinolaryngology-Head and Neck Surgery, Aix Marseille University, 36900APHM, IUSTI, La Conception University Hospital, Marseille, France; 18. Service d’ORL, Hôpital Gabriel Montpied, CHU Clermont Ferrand, Clermont-Ferrand, France; 19. Department of Otorhinolaryngology-Head and Neck Surgery, Sorbonne University, Tenon Hospital, AP-HP, Paris, France; 20. Service de Pneumologie, CHU Rennes, Rennes, France
47
days
Circulating endothelial cells: a key biomarker of persistent fatigue after hospitalization for COVID-19
AuthorsDavid M. Smadja; Sven Günther; Pauline Cavagna; Bertrand Renaud; Dominique Salmon; Bertrand Hermann; Brigitte Ranque; Cédric Lemogne; Jean-Luc Diehl; Aurélien Philippe
Affiliations1. Innovative Therapies in Hemostasis, Paris Cité University, INSERM, Paris, France; 2. Hematology Department, AP-HP, Georges Pompidou European Hospital, Paris, France; 3. Unité d’Explorations Fonctionnelles Respiratoires et du Sommeil, AP-HP, Georges Pompidou European Hospital, Paris, France; 4. Pitié-Salpêtrière Hospital, Pharmacy Department, AP-HP, Paris, France; 5. Paris Cité University, INSERM U970, Paris Cardiovascular Research Centre (PARCC), Paris, France; 6. Hôtel-Dieu Hospital, Infectious Diseases and Immunology Department, AP-HP, Paris, France; 7. Medical Intensive Care Department, AP-HP, Georges Pompidou European Hospital, Paris, France; 8. Internal Medicine Department, AP-HP, Georges Pompidou European Hospital, Paris, France; 9. Paris Cité University and Sorbonne Paris Nord University, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France; 10. Adult Psychiatry Department, AP-HP, Hôtel-Dieu Hospital, Paris, France
14
days
Neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions
AuthorsSagnik Pal; Yangyang Su; Emmanuel Nwadozi; Lena Claesson-Welsh; Mark Richards
Affiliations1. Department of Immunology, Genetics and Pathology, Beijer and Science for Life Laboratories, Uppsala University, Uppsala, Sweden
91
days
Genetic and pharmacological targeting of mTORC1 in mouse models of arteriovenous malformation expose non-cell autonomous signalling in HHT
AuthorsAntonio Queiro-Palou; Yi Jin; Lars Jakobsson
Affiliations1. Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
159
days
Alk1/Endoglin signaling restricts vein cell size increases in response to hemodynamic cues
AuthorsZeenat Diwan; Jia Kang; Emma Tsztoo; Arndt F. Siekmann
Affiliations1. Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; 2. Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, USA
59
days
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancer
AuthorsMarianna Moro; Federica Carolina Balestrero; Giorgia Colombo; Simone Torretta; Nausicaa Clemente; Valerio Ciccone; Erika Del Grosso; Sandra Donnini; Cristina Travelli; Fabrizio Condorelli; Sabina Sangaletti; Armando A. Genazzani; Ambra A. Grolla
Affiliations1. Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy; 2. Division of Hematology/Oncology Department of Medicine, Weill Cornell Medicine, Cornell University, New York, USA; 3. Department of Health Science, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, Novara, Italy; 4. Department of Life Science, Università di Siena, Siena, Italy; 5. Department of Drug Sciences, Università degli Studi di Pavia, Pavia, Italy; 6. Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; 7. Department of Drug Science and Technology, Università di Torino, Turin, Italy
62
days
Inhibition of Angiopoietin-2 rescues sporadic brain arteriovenous malformations by reducing pericyte loss
AuthorsTianqi Tu; Shikun Zhang; Jingwei Li; Chendan Jiang; Jian Ren; Shiju Zhang; Xiaosheng Meng; Hao Peng; Dong Xing; Hongqi Zhang; Tao Hong; Jiaxing Yu
Affiliations1. Department of Neurosurgery, Xuanwu Hospital, International Neuroscience Institute, Capital Medical University, Beijing, China; 2. Department of Neurosurgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China; 3. Sichuan Clinical Research Center for Neurosurgery, The Affiliated Hospital, Southwest Medical University, Luzhou, China; 4. Department of Neurosurgery in Hainan General Hospital, Hainan Medical University, Hainan, China; 5. Department of neurosurgery, The second people’s hospital of hainan province, Hainan, China; 6. Biomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, Peking University, Beijing, China; 7. Beijing Advanced Innovation Center for Genomics (ICG), Peking University, Beijing, China; 8. Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days